Regions Financial Corp’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-9,511
Closed -$226K 874
2019
Q4
$226K Buy
9,511
+126
+1% +$3.06K ﹤0.01% 757
2019
Q3
$258K Sell
9,385
-608
-6% -$18K ﹤0.01% 694
2019
Q2
$330K Sell
9,993
-565
-5% -$19.4K ﹤0.01% 623
2019
Q1
$370K Buy
10,558
+893
+9% +$33.2K ﹤0.01% 600
2018
Q4
$321K Buy
9,665
+2,387
+33% +$103K ﹤0.01% 621
2018
Q3
$366K Buy
7,278
+2,177
+43% +$108K ﹤0.01% 650
2018
Q2
$306K Sell
5,101
-693
-12% -$35.9K ﹤0.01% 698
2018
Q1
$266K Sell
5,794
-1,265
-18% -$52.8K ﹤0.01% 748
2017
Q4
$281K Sell
7,059
-5,431
-43% -$215K ﹤0.01% 751
2017
Q3
$500K Sell
12,490
-3,845
-24% -$166K 0.01% 629
2017
Q2
$704K Sell
16,335
-19,173
-54% -$682K 0.01% 544
2017
Q1
$1.11M Sell
35,508
-15,293
-30% -$410K 0.01% 479
2016
Q4
$1.28M Sell
50,801
-19,364
-28% -$433K 0.02% 432
2016
Q3
$1.74M Sell
70,165
-11,157
-14% -$253K 0.02% 328
2016
Q2
$1.66M Sell
81,322
-6,722
-8% -$119K 0.02% 344
2016
Q1
$1.34M Sell
88,044
-22,373
-20% -$292K 0.02% 422
2015
Q4
$1.48M Buy
110,417
+26,407
+31% +$408K 0.02% 401
2015
Q3
$1.18M Buy
+84,010
New +$1.56M 0.02% 456

Other funds holding SUPN

Regions Financial Corp's SUPN Position: Q1 2020 in Review

Regions Financial Corp sold out of Supernus Pharmaceuticals (SUPN) in Q1 2020, closing a stake of 9,511 shares — an estimated $226K sold.

Regions Financial Corp first reported a position in SUPN in Q3 2015 and held it in 18 quarters. The position peaked at $1.74M in Q3 2016. 208 funds tracked by Wall St. Rank hold SUPN as of Q1 2020.

  • Regions Financial Corp reported no remaining Supernus Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Regions Financial Corp sold 9,511 Supernus Pharmaceuticals shares in Q1 2020, an estimated $226K.
  • Regions Financial Corp first reported a position in Supernus Pharmaceuticals in Q3 2015 and held it in 18 quarters.
  • Regions Financial Corp's Supernus Pharmaceuticals position peaked at $1.74M in Q3 2016.
  • 208 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2020.

Based on Regions Financial Corp's 13F filing for Q1 2020, filed 29 Apr 2020.